Jury selection for the SEC’s MyNyloxin trial was supposed to kick off on March 25th. Instead on March 7th, a Joint Motion was filed requesting the pending trial. The basis for the request was a reached settlement. On March 8th the Joint Motion was granted, requesting the parties file a Status Report or Stipulation of [Continue reading…]

Source: Nutra Pharma Corp settles MyNyloxin fraud with SEC